Joseph Grosso

Joseph Grosso currently serves as the VP, Program Development Team Lead at Merus N.V. since May 2023. Previously, Joseph held positions such as Board Member at Gift of Life Biologics and Vice President of Translational Oncology at Transition Bio, Inc. Joseph's extensive experience at Bristol Myers Squibb includes roles as Breyanzi Program Lead, Early Clinical Development Program Lead in Oncology, and Senior Early Clinical Lead between April 2010 and September 2021. Additionally, Joseph was Chief Scientific Officer at Kleo Pharmaceuticals and Director of Clinical R&D at Celgene. Joseph's academic background includes a Ph.D. in Microbiology and Immunology from the University of Miami Miller School of Medicine and a BS from the University of Rochester.